Schedule 13G ownership disclosure

Keros Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 492327101

Event date: 2025-10-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 2,418,984.00 · Class: 7.9%

  • KEVIN TANG

    Shares: 2,418,984.00 · Class: 7.9%

  • TANG CAPITAL PARTNERS, LP

    Shares: 1,579,237.00 · Class: 5.2%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 839,747.00 · Class: 2.7%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0.0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-015219
Form type
SCHEDULE 13G
Filer
Keros Therapeutics, Inc.
CIK
CIK 1664710
Filed
Oct 22, 2025
Reporting period
Oct 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub